samedan logo
 
 
 
spacer
home > ebr > autumn 2001 > accentus - meeting your contract manufacturing needs
PUBLICATIONS
European Biopharmaceutical Review

Accentus - Meeting Your Contract Manufacturing Needs

Accentus provides high quality, flexible contract services in biopharmaceutical process development and manufacture. Our focus is particularly geared towards meeting the needs of young biotech companies with products in the early stages of clinical development. We help companies make the transition from lab-scale research to processes suitable for the industrial manufacture of their products.We opened a state-of-the-art facility in March 2000, designed to meet the current shortfall in available capacity for biologics manufacture. Situated on the outskirts of Oxford in the UK, our facility has been used for the GMP manufacture of Phase I and II clinical trial material.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

 You must be a member of the site to make a comment.
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Bio-Rad Introduces Bio-Plex Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays to Quickly Measure Neutralizing Antibodies Against SARS-CoV-2 Virus

HERCULES, Calif.–December 20, 2021–Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced the launch of the Bio-Plex™ Pro Human SARS-CoV-2 Variant Neutralization Antibody Assays, for research use only (RUO).
More info >>

White Papers

Customising the Cold Chain

World Courier

Of all the statistics emerging around the global pharmaceutical industry this year, two big numbers capture the attention of both manufacturers and their logistics partners: $248 billion, the amount the “BRIC” nations (Brazil, Russia, India and China) are poised to account for in pharmaceutical sales for by 2016; and $8 billion, the amount global pharma will spend on cold chain logistics in 2014. Why are these two numbers so noteworthy? They demonstrate that as R&D goes, so goes logistics. As products evolve to meet demands for more targeted therapies, demand for more targeted logistics solutions grows as well. And that means a need for customization for everything from clinical trial samples to finished product.
More info >>

 

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement